共 75 条
[1]
Khan S.A., Taylor-Robinson S.D., Toledano M.B., Beck A., Elliott P., Thomas H.C., Changing international trends in mortality rates for liver, biliary and pancreatic tumours, Journal of Hepatology, 37, 6, pp. 806-813, (2002)
[2]
Shaib Y., El-Serag H.B., The epidemiology of cholangiocarcinoma, Seminars in Liver Disease, 24, 2, pp. 115-125, (2004)
[3]
Jemal A., Murray T., Ward E., Et al., Cancer statistics, 2005, CA Cancer J Clin, 55, pp. 10-30, (2005)
[4]
Broome U., Olsson R., Loof L., Et al., Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis, Gut, 38, pp. 610-15, (1996)
[5]
Pitt H.A., Nakeeb A., Abrams R.A., Et al., Perihilar cholangiocarcinoma: Postoperative radiotherapy does not improve survival, Ann Surg, 221, pp. 788-98, (1995)
[6]
Bergquist A., Glaumann H., Persson B., Broome U., Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A case-control study, Hepatology, 27, 2, pp. 311-316, (1998)
[7]
Chalasani N., Baluyut A., Ismail A., Et al., Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study, Hepatology, 31, pp. 7-11, (2000)
[8]
Patel T., Worldwide trends in mortality from biliary tract malignancies, BMC Cancer, 2, (2002)
[9]
Patel T., Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States, Hepatology, 33, 6, pp. 1353-1357, (2001)
[10]
Watanapa P., Watanapa W.B., Liver fluke-associated cholangiocarcinoma, British Journal of Surgery, 89, 8, pp. 962-970, (2002)